These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940 [TBL] [Abstract][Full Text] [Related]
9. Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma. Sin KM; Ho SK; Wong BY; Gill H; Khong PL; Lee EY Clin Imaging; 2017; 42():25-33. PubMed ID: 27875758 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil. Cerci JJ; Pracchia LF; Soares Junior J; Linardi Cda C; Meneghetti JC; Buccheri V Clinics (Sao Paulo); 2009; 64(6):491-8. PubMed ID: 19578651 [TBL] [Abstract][Full Text] [Related]
11. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma. Qiu L; Chen Y; Wu J Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577 [TBL] [Abstract][Full Text] [Related]
12. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707 [TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335 [TBL] [Abstract][Full Text] [Related]
14. [Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment]. Mainolfi C; Maurea S; Varrella P; Alaia C; Imparato C; Alfano B; Abate G; Bazzicalupo L Radiol Med; 1998; 95(1-2):98-104. PubMed ID: 9636735 [TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. Picardi M; Soricelli A; Pane F; Zeppa P; Nicolai E; De Laurentiis M; Grimaldi F; Rotoli B Radiology; 2009 May; 251(2):574-82. PubMed ID: 19401581 [TBL] [Abstract][Full Text] [Related]
16. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Hernandez-Pampaloni M; Takalkar A; Yu JQ; Zhuang H; Alavi A Pediatr Radiol; 2006 Jun; 36(6):524-31. PubMed ID: 16622665 [TBL] [Abstract][Full Text] [Related]
17. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
18. Staging in childhood lymphoma: differences between FDG-PET and CT. Hermann S; Wormanns D; Pixberg M; Hunold A; Heindel W; Jürgens H; Schober O; Franzius C Nuklearmedizin; 2005 Feb; 44(1):1-7. PubMed ID: 15711722 [TBL] [Abstract][Full Text] [Related]
19. The role of FDG-PET imaging in the management of lymphoma. Kostakoglu L; Leonard JP; Coleman M; Goldsmith SJ Clin Adv Hematol Oncol; 2004 Feb; 2(2):115-21. PubMed ID: 16163171 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]